Coloplast AS (CLPBY)
11.09
+0.21
(+1.93%)
USD |
OTCM |
Dec 20, 16:00
Coloplast Shareholders Equity (Quarterly): 2.687B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Genmab AS | 4.781B |
| Ascendis Pharma AS | -108.70M |
| Galecto Inc | 20.94M |
| Evaxion Biotech AS | 0.074M |
| IO Biotech Inc | 72.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.200B |
| Total Liabilities (Quarterly) | 4.513B |
| Debt to Equity Ratio | 1.206 |
| Current Ratio | 1.024 |
| Net Debt Paydown Yield | -0.10% |